Fitness cost of drug resistance mutations is relative and is modulated by other resistance mutations:: implications for persistance of transmitted resistance

被引：0
|
作者：
Cong, M [1 ]
Bennett, DE [1 ]
Heneine, W [1 ]
García-Lerma, JG [1 ]
机构：
[1] NCHSTP, Div HIV AIDS, CDC, Atlanta, GA USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
154
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [31] Viral fitness: relation to drug resistance mutations and mechanisms involved: nucleoside reverse transcriptase inhibitor mutations
    Weber, Jan
    Henry, Kenneth R.
    Arts, Eric J.
    Quinones-Mateu, Miguel E.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2007, 2 (02) : 81 - 87
  • [32] Interactions between nevirapine resistance mutations and NRTI resistance mutations
    Deforche, K
    Camacho, R
    Grossman, Z
    Silander, T
    Soares, MA
    Shafer, RW
    Van Laethem, K
    Carvalho, AP
    Wynhoven, B
    Cane, P
    Clarke, J
    Snoeck, J
    Sirivichayakul, S
    Ariyoshi, K
    Holguin, A
    Rudich, H
    Rodrigues, R
    Bouzas, MB
    Brun-Vézinet, F
    Cahn, P
    Brigido, LF
    Soriano, V
    Sugiura, W
    Phanuphak, P
    Morris, L
    Weber, J
    Pillay, D
    Tanuri, A
    Harrigan, PR
    Schapiro, JM
    Katzenstein, D
    Kantor, R
    Vandamme, AM
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S144 - S144
  • [33] Interactions between nevirapine resistance mutations and NRTI resistance mutations
    Deforche, K
    Camacho, R
    Grossman, Z
    Silander, T
    Soares, MA
    Shafer, RW
    Van Laethem, K
    Carvalho, AP
    Wynhoven, B
    Cane, P
    Clarke, J
    Snoeck, J
    Sirivichayakul, S
    Ariyoshi, K
    Holguin, A
    Rudich, H
    Rodrigues, R
    Bouzas, MB
    Brun-Vézinet, F
    Cahn, P
    Brigido, LF
    Soriano, V
    Sugiura, W
    Phanuphak, P
    Morris, L
    Weber, J
    Pillay, D
    Tanuri, A
    Harrigan, PR
    Schapiro, JM
    Katzenstein, D
    Kantor, R
    Vandamme, AM
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S144 - S144
  • [34] Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations
    Kessler, Harald H.
    Stelzl, Evelyn
    Blazic, Anja
    Mehta, Sanjay R.
    Benezeder, Anna S.
    Genger-Hackl, Christina
    Santner, Brigitte I.
    Chaillon, Antoine
    Hoenigl, Martin
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (01):
  • [35] Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations
    zur Wiesch, Pia Schulz
    Engelstaedter, Jan
    Bonhoeffer, Sebastian
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 2085 - 2095
  • [36] Long term resistance selection to NNRTIs: Mutations in reverse transcriptase and other viral genes and their contribution to resistance and viral fitness
    Buckheit, RW
    Hartman, TL
    Watson, KM
    Russell, JL
    Pallansch, LA
    Turpin, JA
    [J]. ANTIVIRAL RESEARCH, 2002, 53 (03) : A48 - A48
  • [37] Impact of Fluoroquinolone Resistance Mutations on Gonococcal Fitness and In Vivo Selection for Compensatory Mutations
    Kunz, Anjali N.
    Begum, Afrin A.
    Wu, Hong
    D'Ambrozio, Jonathan A.
    Robinson, James M.
    Shafer, William M.
    Bash, Margaret C.
    Jerse, Ann E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (12): : 1821 - 1829
  • [38] Fitness cost of drug resistance in Mycobacterium tuberculosis
    Gagneux, S.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 66 - 68
  • [39] Secondary Mutations Correct Fitness Defects in Toxoplasma gondii With Dinitroaniline Resistance Mutations
    Ma, Christopher
    Tran, Johnson
    Li, Catherine
    Ganesan, Lakshmi
    Wood, David
    Morrissette, Naomi
    [J]. GENETICS, 2008, 180 (02) : 845 - 856
  • [40] Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
    Rhee, Soo-Yon
    Tzou, Philip L.
    Shafer, Robert W.
    [J]. VIRUSES-BASEL, 2021, 13 (05):
12345